Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expression
Chinese Journal of Cancer · 05.02.2012 · 31 (2) · 73-99
DOI: 10.5732/cjc.011.10320 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Chinese Journal of Cancer, erschienen am 05.02.2012. Verfasst von Takeo Nakanishi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Membrane Transport and Biopharmaceutics, Kanazawa University School of Pharmaceutical Sciences, Kanazawa, Japan. nakanish@p.kanazawa-u.…. Hauptthemen laut MEDLINE: Drug Resistance, Multiple, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 264-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Membrane Transport and Biopharmaceutics, Kanazawa University School of Pharmaceutical Sciences, Kanazawa, Japan. nakanish@p.kanazawa-u.ac.jp
Zitieren
APA
Nakanishi, T., & Ross, D. D. (2012). Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expression. Chinese Journal of Cancer, 31(2), 73-99. https://doi.org/10.5732/cjc.011.10320
Vancouver
Nakanishi T, Ross DD. Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expression. Chinese Journal of Cancer. 2012;31(2):73-99. doi:10.5732/cjc.011.10320
BibTeX
@article{Nakanishi2012,
author = {Nakanishi, Takeo and Ross, Douglas D},
title = {Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expression},
journal = {Chinese Journal of Cancer},
year = {2012},
volume = {31},
number = {2},
pages = {73--99},
doi = {10.5732/cjc.011.10320}
}
EUVIMED